ARE BIOMARKERS FOR CARDIOVASCULAR DISEASE INCREASED IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)?

被引：0
|
作者：
Elsheikh, Elzafir
Tran, Henry A.
Paik, James
Felix, Sean C.
Jeffers, Thomas
Younoszai, Zahra
Locklear, Cameron T.
Allawi, Hussain
Fang, Yun
Arsalla, Aimal
Noor, Bashir
Kalachi, Kourosh
Racila, Andrei
Lam, Brian P.
Goodman, Zachary
Gerber, Lynn
Younossi, Zobair M.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1516
引用
收藏
页码：S950 / S950
页数：1
相关论文
共 50 条
  • [31] Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in Patients with Morbid Obesity
    Manno, Emilio
    OBESITY SURGERY, 2010, 20 (06) : 811 - 811
  • [32] Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
    Gerhardt, Florian
    Petroff, David
    Blank, Valentin
    Boehlig, Albrecht
    van Boemmel, Florian
    Wittekind, Christian
    Berg, Thomas
    Karlas, Thomas
    Wiegand, Johannes
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (06) : 706 - 711
  • [33] Noninvasive Diagnostics in Nonalcoholic Fatty Liver Disease (NAFLD)
    Stauber R.
    Journal für Gastroenterologische und Hepatologische Erkrankungen, 2019, 17 (3) : 75 - 81
  • [34] An endocrine perspective of nonalcoholic fatty liver disease (NAFLD)
    Lomonaco, Romina
    Chen, Janet
    Cusi, Kenneth
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2011, 2 (05) : 211 - 225
  • [35] Developmental Origins of Nonalcoholic Fatty Liver Disease (NAFLD)
    Itoh, Hiroaki
    Kanayama, Naohiro
    DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD): FROM BIOLOGICAL BASIS TO CLINICAL SIGNIFICANCE, 2018, 1012 : 29 - 39
  • [36] Vitamin E and nonalcoholic fatty liver disease (NAFLD)
    Thakur, Varsha
    Ulatowski, Lynn
    Parker, Robert
    Zhang, Renliang
    Liu, Xiuli
    Manor, Danny
    FASEB JOURNAL, 2013, 27
  • [37] Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)
    Boudaoud, Amel Ait
    Rives-Lange, Claire
    Perregaux, Jean Francois
    Radu, Alina
    Messager-Josipowicz, Diane
    Barsamian, Charles
    Carette, Claire
    Czernichow, Sebastien
    PRESSE MEDICALE, 2019, 48 (12): : 1496 - 1501
  • [38] Intestinal permeability in nonalcoholic fatty liver disease (NAFLD).
    Miele, L
    Valenza, V
    Mascianà, R
    Gabrieli, ML
    Perotti, G
    Cammarota, G
    Montalto, M
    Forgione, A
    Vero, V
    Gasbarrini, G
    Grieco, A
    HEPATOLOGY, 2004, 40 (04) : 585A - 585A
  • [39] Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients
    Mikolasevic, I.
    Racki, S.
    Zaputovic, L.
    Lukenda, V.
    Milic, S.
    Orlic, L.
    MEDICAL HYPOTHESES, 2014, 82 (02) : 205 - 208
  • [40] Die nichtalkoholische Fettlebererkrankung (NAFLD)Nonalcoholic fatty liver disease (NAFLD)
    S. Zeuzem
    C. Trautwein
    Der Gastroenterologe, 2020, 15 (2): : 77 - 77
12345